The numbuzin No.3 Bifida Bakuchiol Zero Pore Serum is a facial serum formulated to address pore visibility, skin texture, and uneven tone. This product contains bifida ferment lysate, bakuchiol, and kojic acid as key ingredients. Bifida ferment lysate is a probiotic-derived component often included in skincare to support skin barrier function and resilience. Bakuchiol serves as a plant-based alternative to retinol, offering gentle exfoliation and smoothing benefits without the irritation commonly associated with retinoids, making it suitable for sensitive skin types. Kojic acid, a natural skin-brightening agent derived from fungi, is incorporated to help reduce the appearance of hyperpigmentation and promote a more even skin tone.

The serum is designed to minimize and tighten the appearance of pores by targeting excess sebum and refining skin surface texture. It aims to smooth rough or uneven areas, contributing to a softer, more uniform complexion. The formulation is lightweight and non-greasy, allowing for easy absorption without leaving a heavy residue. This product is particularly suited for individuals with sensitive skin who seek pore-minimizing and texturizing benefits but prefer to avoid harsh active ingredients like high-concentration retinol or acids. It can be incorporated into a daily skincare routine, applied after cleansing and before moisturizer, for both morning and evening use.

The packaging contains 1.01 fluid ounces of product. The serum is free from added fragrances and essential oils, reducing the likelihood of skin reactions. It is priced at an accessible range, emphasizing value for those seeking gentle, effective skincare without premium markups. While results may vary based on individual skin conditions and consistent use, the formula relies on established ingredients to deliver gradual improvements in pore appearance, texture, and tone. This description focuses solely on the product’s composition, intended functions, and target audience, without referencing user experiences or subjective claims.